申请人:Månsson Kristoffer
公开号:US20130267516A1
公开(公告)日:2013-10-10
Compounds of general formula I, (formula [I)], their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroidism, pharmaceutical compositions comprising said compounds, and methods of treating diseases with said compounds.
一般式I的化合物(公式[I]),它们作为钙受体活性化合物用于预防、治疗或改善与CaSR活性紊乱有关的生理障碍或疾病,例如甲状旁腺功能亢进症,包括该化合物的制药组合物以及使用该化合物治疗疾病的方法。